share_log

PanGenomic Health Announces Director Resignations

PanGenomic Health Announces Director Resignations

PangeNomic Health 宣佈董事辭職
PR Newswire ·  2023/07/14 05:30

VANCOUVER, BC, July 13, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), announced today that independent directors, Peter Green and Jonathan Lutz, tendered their resignations effective as of July 12, 2023.

溫哥華不列顛哥倫比亞省溫哥華,2023年7月13日/cnw/-泛基因組健康公司(“泛基因組健康”或“公司”)(CSE:NARA)(AQSE:NRA)今天宣佈,獨立董事Peter Green和Jonathan Lutz已遞交辭呈,自2023年7月12日起生效。

"We wish to thank Peter and Jonathan for all of their valuable guidance as PanGenomic matured from a private health tech startup to one of the first publicly-listed benefit companies in both Canada and the UK last year", said Robert Nygren, Executive Chair and Co-Founder of PanGenomic Health.

泛基因組健康執行主席兼聯合創始人羅伯特·尼格倫表示:“我們要感謝彼得和喬納森在去年從一傢俬人健康科技初創公司成長為加拿大和英國首批上市福利公司之一的過程中提供的所有寶貴指導。”

About PanGenomic Health

關於泛基因組健康

PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. The Company's initial focus is to support mental health. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.

泛基因組健康是一家精確的健康公司,它已經開發了一個自我護理數位平臺,以提供關於自然治療的個性化、循證資訊。該公司最初的重點是支持心理健康。註冊為不列顛哥倫比亞省福利公司的泛基因組健康公司的使命是通過提供一個技術平臺來識別針對每個人的健康狀況量身定做的植物性解決方案,從而促進和改善人們和社會的健康和福祉。

The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.

加拿大證券交易所既不批准也不反對本新聞稿中包含的資訊,也不對本新聞稿的充分性或準確性承擔責任。

SOURCE  PanGenomic Health Inc.

來源:泛基因組健康公司。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論